ASX-listed small-cap drug companies are soaring as two firms announce plans to take advantage of Australia's medical regulator relaxing the rules around two mind-altering drugs.The Therapeutic Goods Administration on Friday announced it was down-scheduling psilocybin and MDMA, allowing both to dispensed as of July 1 by authorised psychiatrists to treat certain mental health conditions.
Australia's biggest goldminer says it has received a tentative $24.3 billion takeover offer from the world's largest one.
Insurance Australia Group says it will miss insurance margin targets after experiencing claims inflation and more than 15,000 claims related to last weekend's severe flooding in Auckland.The company behind the NRMA, CGU, SGIO, SGIC and WFI brands said on Friday while the financial impact of the Auckland storms was difficult to judge at this early stage, it expects their gross costs to exceed $350 million.